Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Machine learning identifies proteomic risk factors across 23 diseases
Lingqi Meng1, Mengzhen Li1, Xiangtai Kong1
1Science for Life Laboratory, KTH Royal Institute of Technology, 17165 Stockholm, Sweden.
This study introduces a novel two-stage hierarchical classifier for multi-disease detection using plasma proteomics. Domain expertise enhances machine learning for accurate and rapid disease screening.
Area of Science:
- Biomedical Science
- Proteomics
- Machine Learning in Medicine
Background:
- Early disease detection is vital for effective medical intervention.
- Plasma proteome analysis offers potential for understanding disease and improving patient outcomes.
- Current diagnostic methods can be invasive and lack speed.
Purpose of the Study:
- To develop and validate a novel classifier for multi-disease detection using plasma proteomic data.
- To assess the performance of a domain-expertise-guided hierarchical classifier against traditional machine learning algorithms.
- To explore the utility of plasma proteomics for broad disease screening.
Main Methods:
- Collected plasma proteomic data from over 3000 patients across 23 diseases, analyzing 1462 proteins.
- Developed a two-stage hierarchical classifier integrating histological knowledge.
- Applied the classifier to multi-disease classification and compared its performance with standard machine learning approaches.
Main Results:
- The developed hierarchical classifier demonstrated superior prediction performance compared to traditional machine learning methods.
- The classifier exhibited improved feature selection and a better balance in classification outcomes.
- Empirical guidance from domain expertise significantly enhanced the machine learning model's effectiveness.
Conclusions:
- Integrating domain expertise into machine learning models improves disease detection accuracy.
- Plasma proteomics is a promising tool for multi-disease screening and early diagnosis.
- The developed classifier shows potential for minimally invasive and rapid medical diagnostics.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Machines
A free-body diagram of the...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Relative Risk

